Humacyte, Inc. (HUMA)
0.6852
-0.02
(-2.28%)
USD |
NASDAQ |
Aug 26, 16:00
0.6852
0.00 (0.00%)
After-Hours: 18:23
Humacyte Market Cap : 190.35M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 194.79M |
| August 24, 2026 | 183.96M |
| August 21, 2026 | 178.40M |
| August 20, 2026 | 189.29M |
| August 19, 2026 | 204.15M |
| August 18, 2026 | 161.60M |
| August 17, 2026 | 155.73M |
| August 14, 2026 | 168.01M |
| August 13, 2026 | 152.79M |
| August 12, 2026 | 184.74M |
| August 11, 2026 | 197.24M |
| August 10, 2026 | 206.82M |
| August 07, 2026 | 159.45M |
| August 06, 2026 | 157.54M |
| August 05, 2026 | 161.81M |
| August 04, 2026 | 158.12M |
| August 03, 2026 | 153.04M |
| July 31, 2026 | 145.07M |
| July 30, 2026 | 149.11M |
| July 29, 2026 | 138.67M |
| July 28, 2026 | 140.03M |
| July 27, 2026 | 149.66M |
| July 24, 2026 | 138.72M |
| July 23, 2026 | 141.78M |
| July 22, 2026 | 143.11M |
| Date | Value |
|---|---|
| July 21, 2026 | 148.93M |
| July 20, 2026 | 145.69M |
| July 17, 2026 | 147.58M |
| July 16, 2026 | 146.44M |
| July 15, 2026 | 151.33M |
| July 14, 2026 | 157.01M |
| July 13, 2026 | 153.46M |
| July 10, 2026 | 154.01M |
| July 09, 2026 | 155.48M |
| July 08, 2026 | 162.78M |
| July 07, 2026 | 171.15M |
| July 06, 2026 | 171.09M |
| July 02, 2026 | 157.63M |
| July 01, 2026 | 149.33M |
| June 30, 2026 | 173.26M |
| June 29, 2026 | 177.37M |
| June 26, 2026 | 157.32M |
| June 25, 2026 | 137.65M |
| June 24, 2026 | 154.90M |
| June 23, 2026 | 155.50M |
| June 22, 2026 | 186.34M |
| June 18, 2026 | 205.23M |
| June 17, 2026 | 215.11M |
| June 16, 2026 | 228.68M |
| June 15, 2026 | 237.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 238.03B |
| Altimmune, Inc. | 613.57M |
| Protalix Biotherapeutics, Inc. | 199.41M |
| Taysha Gene Therapies, Inc. | 1.957B |
| Agenus, Inc. | 351.37M |
Market Cap Related Metrics
| PS Ratio | 62.76 |
| PEG Ratio | -0.1930 |
| Price to Book Value | 6.089 |
| Price | 0.6852 |
| Earnings Yield | -71.45% |
| PEGY Ratio | -0.1930 |